Alpha Tau Medical stock completes 48 patient trial enrollment

By yozmakorea2026-10-01No Comments

Home » Alpha Tau Medical stock completes 48 patient trial enrollment

Read the latest report on Alpha Tau Medical from AD HOC NEWS.

See the original article for the full details.

Source: AD HOC NEWS

Read the original article

Previous PostDon't Delay NAVER-Dunamu Merger Review Any Longer,' Lawmaker Says
Next PostBL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting

서울 오피스 / Seoul Office
서울시 강남구 봉은사로 457 S&C TOWER 9층
9F, S&C TOWER, 457, Bongeunsa-ro, Gangnam-gu, Seoul, Republic of Korea
t. +82 2 6949 5350
e. [email protected]

Israel Office
2 Ben Gurion way, BSR 1 building fl 14, Ramat Gan, Israel
e. [email protected]

Family Site
Yozma Group Israel HQ
Yozma Campus (PR/Marketing)

Privacy Policy

Alpha Tau Medical stock completes 48 patient trial enrollment

Previous PostDon't Delay NAVER-Dunamu Merger Review Any Longer,' Lawmaker Says

Next PostBL Pharmtech Decides on 10-to-1 Reverse Stock Split, Aiming to Reduce Risk of Delisting